Healthcare Coverage

Study reveals little risk in insuring HIV positive patients in Holland

Published in Cancer Weekly, April 12th, 2005

The Dutch Association of Insurers has announced the results of a study revealing that there is little risk in providing life insurance policies to HIV patients in the Netherlands undergoing highly active antiretroviral therapy (HAART).

In response to the study's findings, several of the association's members have begun offering life insurance to patients in this category. These member companies are among the first in the world to provide life insurance for HIV patients on a commercial basis.

"These findings show that someone with HIV is no more of a risk factor for insurers than someone with diabetes - a positive first step toward increasing the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2005-04-12)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry